QIAGEN Shareholders Overwhelmingly Approve Jonathan M. Pratt as Managing DirectorBusiness Wire • 11/06/26
Compared to Estimates, Qiagen (QGEN) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 11/05/26
Qiagen (QGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/28/26
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ultralife Corporation (Nasdaq – ULBI), QIAGEN N.V. (NYSE – QGEN), CCC Intelligent Solutions Holdings Inc. (Nasdaq – CCC), Penske Automotive Group, Inc. (NYSE – PAG)GlobeNewsWire • 10/28/26
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: QIAGEN N.V. (NYSE – QGEN), Varonis Systems, Inc. (Nasdaq – VRNS), CCC Intelligent Solutions Holdings Inc. (Nasdaq – CCC), Penske Automotive Group, Inc. (NYSE – PAG)GlobeNewsWire • 10/22/26
QGEN Stock Alert: Halper Sadeh LLC is Investigating Whether QIAGEN N.V. is Obtaining a Fair Price for its ShareholdersBusiness Wire • 10/22/26
QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offerBusiness Wire • 10/21/26
QIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against TuberculosisBusiness Wire • 10/13/26
QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared PanelZacks Investment Research • 10/02/26
QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection PanelBusiness Wire • 09/28/26
Here's Why You Should Hold QIAGEN Stock in Your Portfolio for NowZacks Investment Research • 09/24/26
QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing BoardBusiness Wire • 09/18/26
Qiagen N.V. (QGEN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Qiagen (QGEN) Up 5.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 09/04/26